îæ€çŽ¢
îæ€çŽ¢
î
Alkermes Plc
ALKSîãŠã©ãããªã¹ãã«è¿œå
42.240USD
-1.050-2.43%
ååŒæé 09/23, 11:05ïŒETïŒ
7.09Bæ䟡ç·é¡
45.43çŽè¿12ã¶æPER
Alkermes PlcïŒALKSïŒå£²äžããã©ãŒãã³ã¹
æŽæ°æå»: Jun 30, 2026æšå¹ŽãAlkermes Plcã¯æãæ¥çžŸã®è¯ãã£ãéšéã§ããVIVITROLã§467.91M USDã®å£²äžãèšäžããŸãããå°åå¥ã§ã¯United Statesãæã倧ããè²¢ç®ããæšå¹Žã®å£²äžé«ã¯1.37B USDã«éããŸããã
äºæ¥å¥
åç
æ¯ç
幎éî®
幎é
ååæ
VIVITROL
ARISTADA
LYBALVI
Royalty Revenue - VUMERITY
Royalty-INVEGA SUSTENNA/XEPLION & INVEGA TRINZA/TREVICTA
Royalty-Other
Manufacturing-RISPERDAL CONSTA
Manufacturing Revenue - VUMERITY
Manufacturing-Other
Royalty-RISPERDAL CONSTA
Manufacturing-AMPYRA/FAMPYRA
Royalty-AMPYRA/FAMPYRA
Manufacturing-INVEGA SUSTENNA/XEPLION & INVEGA TRINZA/TREVICTA
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
VIVITROL
467.91M(31.70%)
457.31M(29.36%)
400.42M(24.07%)
379.48M(34.20%)
343.85M(29.62%)
310.72M(30.00%)
335.37M(34.49%)
ARISTADA
370.04M(25.07%)
346.19M(22.23%)
327.69M(19.70%)
302.05M(27.22%)
275.36M(23.72%)
241.04M(23.27%)
189.13M(19.45%)
LYBALVI
346.69M(23.49%)
280.03M(17.98%)
191.89M(11.54%)
96.02M(8.65%)
--(--)
--(--)
--(--)
Royalty Revenue - VUMERITY
113.93M(7.72%)
94.75M(6.08%)
86.44M(5.20%)
83.00M(7.48%)
61.61M(5.31%)
--(--)
--(--)
Royalty-INVEGA SUSTENNA/XEPLION & INVEGA TRINZA/TREVICTA
109.57M(7.42%)
236.39M(15.18%)
486.10M(29.22%)
115.66M(10.42%)
303.11M(26.11%)
274.20M(26.47%)
256.95M(26.42%)
Royalty-Other
21.70M(1.47%)
23.26M(1.49%)
27.20M(1.63%)
13.71M(1.24%)
40.52M(3.49%)
55.31M(5.34%)
55.56M(5.71%)
Manufacturing-RISPERDAL CONSTA
19.57M(1.33%)
23.17M(1.49%)
36.12M(2.17%)
42.67M(3.85%)
40.41M(3.48%)
56.89M(5.49%)
50.43M(5.19%)
Manufacturing Revenue - VUMERITY
16.54M(1.12%)
39.29M(2.52%)
42.89M(2.58%)
32.49M(2.93%)
25.81M(2.22%)
--(--)
--(--)
Manufacturing-Other
9.89M(0.67%)
56.96M(3.66%)
63.49M(3.82%)
37.21M(3.35%)
12.00M(1.03%)
35.23M(3.40%)
31.75M(3.27%)
Royalty-RISPERDAL CONSTA
55.00K(--)
272.00K(0.02%)
1.15M(0.07%)
7.24M(0.65%)
10.46M(0.90%)
14.47M(1.40%)
15.95M(1.64%)
Manufacturing-AMPYRA/FAMPYRA
--(--)
--(--)
--(--)
--(--)
27.41M(2.36%)
26.91M(2.60%)
22.07M(2.27%)
Royalty-AMPYRA/FAMPYRA
--(--)
--(--)
--(--)
--(--)
20.48M(1.76%)
20.98M(2.03%)
15.17M(1.56%)
Manufacturing-INVEGA SUSTENNA/XEPLION & INVEGA TRINZA/TREVICTA
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
å°åå¥
åç
æ¯ç
幎éî®
幎é
ååæ
United States
Rest of the World
Ireland
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
1.37B(93.01%)
1.41B(90.53%)
1.49B(89.69%)
931.99M(83.83%)
984.24M(83.85%)
839.00M(80.77%)
966.93M(82.58%)
Rest of the World
102.36M(6.94%)
146.18M(9.38%)
170.29M(10.24%)
177.97M(16.01%)
187.34M(15.96%)
196.53M(18.92%)
200.82M(17.15%)
Ireland
754.00K(0.05%)
1.29M(0.08%)
1.18M(0.07%)
1.83M(0.16%)
2.17M(0.19%)
3.23M(0.31%)
3.19M(0.27%)